217 results
8-K
EX-99.1
JAZZ
Jazz Pharmaceuticals plc
1 May 24
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results
4:06pm
and commercialization strategy, including the Company's expectations to executing multiple Epidyolex launches through 2024; the Company’s expectations … related thereto; the Company’s capital allocation and corporate development strategy; the potential successful future development, manufacturing
8-K
EX-99.1
v3p6a
28 Feb 24
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
k4u5cxv
21 Feb 24
Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer
7:46am
8-K
EX-99.1
3dpr rxm3f7gi
8 Nov 23
Jazz Pharmaceuticals Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
4:07pm
8-K
2izrq847ilb6vo1gy8ff
12 Sep 23
Departure of Directors or Certain Officers
7:36am
8-K
EX-99.1
csbhbnk
9 Aug 23
Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance
4:07pm
8-K
EX-99.1
lp6dppk0fbg24i 111r
10 May 23
Jazz Pharmaceuticals Announces First Quarter 2023 Financial Results and Affirms 2023 Financial Guidance
4:08pm
8-K
EX-2.1
0rqnds44
5 Dec 22
Completion of Acquisition or Disposition of Assets
4:16pm